USP49 and colorectal cancer: For example, Zhuang et al. suggested that miR-5000-3p facilitated oxaliplatin resistance by targeting USP49 in colorectal cancer [32]; Chen et al. indicated that overexpression of miR-5000-3p enhanced proliferation and migration of laryngocarcinoma [33].